Learn about Bydureon BCise (extended-release exenatide), which is a prescription injection used for type 2 diabetes in certain adults and children.

First and Only Once-Weekly Type 2 Diabetes Medication Delivers Powerful Glycemic Control in a Single DoseINDIANAPOLIS, SAN DIEGO and WALTHAM, Mass., June 21, 2011 /PRNewswire/ -- Eli Lilly and ...

WILMINGTON, Del., Jan. 10, 2018 /PRNewswire/ -- AstraZeneca today announced that BYDUREON ® BCise™ (exenatide extended-release) injectable suspension 2mg is now available in pharmacies across ...

Bydureon BCise is a prescription drug used to treat type 2 diabetes in adults and some children. Learn about the drug’s dosage, form, strength, and more.

According to Mark Schoenebaum, the analyst at ISI Group, Amylin will be allowed to conduct its heart rhythm study of the drug Bydureon using an IV formulation of its ...

The FDA approved Amylin Pharmaceuticals' diabetes drug Bydureon after a prolonged regulatory process to address safety concerns.